Stocks · News reference
Truist Securities analyst Gabe Daoud maintains BKV (NYSE:BKV) with a Buy and raises the price target from $33 to $34.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
BKV (NYSE:BKV) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and financial
BKV stock rises after securing a power equipment deal backed by a major hyperscaler for a 1,200 MW Texas project.
U.S. stocks fell Wednesday, led by industrials. Crude inventories dropped unexpectedly, while Penguin Solutions and Lipocine surged; Caribou Biosciences